A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
for Cervical Cancer
Sites in La Jolla, San Diego +115 more locations
Sponsor: GOG Foundation
Sex: Female·Age: 18+
Code: NCT04831580·Recruiting·Listed Apr 2021
Oncology Clinical Trials in La Jolla, CA
As of September 2026, 125 paid clinical trials are recruiting for Oncology in La Jolla, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
125 clinical trials for Oncology
·Clear filters· Email me when a new oncology trial opens in La Jolla, CA.
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
for Anatomic Stage IV Breast Cancer AJCC v8
Sites in La Jolla, San Diego +255 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06500455·Phase 3·Recruiting·Listed Jul 2024
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for Malignant Female Reproductive System Neoplasm
Sites in La Jolla, San Diego +176 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06126276·Phase 2·Recruiting·Listed Nov 2023
Pancreatic Cancer Early Detection Consortium
for Pancreas Cancer
Sites in La Jolla, Newport Beach +40 more locations
Sponsor: Arbor Research Collaborative for Health
Sex: All·Age: 18 - 90·Accepts healthy volunteers
Code: NCT04970056·Recruiting·Listed Jul 2021
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
for Glioblastoma
Sites in La Jolla, Orange +19 more locations
Sponsor: Global Coalition for Adaptive Research
Sex: All·Age: 18+
Code: NCT03970447·Phase 2, Phase 3·Recruiting·Listed May 2019
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
for Advanced Malignant Solid Neoplasm
Sites in La Jolla, San Diego +20 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05327010·Phase 2·Recruiting·Listed Apr 2022
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
for Anatomic Stage IV Breast Cancer AJCC v8
Sites in La Jolla, San Diego +56 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06500481·Phase 3·Recruiting·Listed Jul 2024
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for Hematologic Malignancies
Sites in La Jolla, San Diego +111 more locations
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All·Age: All ages
Code: NCT01351545·Recruiting·Listed May 2011
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
for Metastatic Malignant Solid Neoplasm
Sites in La Jolla, San Diego +16 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05687110·Phase 1·Recruiting·Listed Jan 2023
Precision-Based Genomics in Prostate Cancer
for Prostate Cancer
Sites in La Jolla, San Francisco +9 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Male·Age: 18 - 120
Code: NCT04706663·Recruiting·Listed Jan 2021
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
for Advanced Malignant Solid Neoplasm
Sites in La Jolla, San Diego +25 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06311214·Phase 2·Recruiting·Listed Mar 2024
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for Clinical Stage III Cutaneous Melanoma AJCC v8
Sites in La Jolla, Los Angeles +23 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05896839·Phase 1, Phase 2·Recruiting·Listed Jun 2023
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for Lung Non-Small Cell Carcinoma
Sites in La Jolla, Rancho Mirage +241 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
for Breast Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: 18+
Code: NCT07227233·Phase 2·Recruiting·Listed Nov 2025
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
for Anatomic Stage I Breast Cancer AJCC v8
Sites in La Jolla, Riverside & Duarte
Sponsor: City of Hope Medical Center
Sex: Female·Age: 18+
Code: NCT06763328·Phase 3·Recruiting·Listed Jan 2025
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for Breast Neoplasms
Sites in La Jolla, Newport Beach +31 more locations
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All·Age: 18+
Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
for Pancreatic Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: 18+
Code: NCT06205849·Phase 1·Recruiting·Listed Jan 2024
TERPS Trial for de Novo Oligometastic Prostate Cancer
for Prostate Cancer
Sites in La Jolla +9 more locations
Sponsor: University of Maryland, Baltimore
Sex: Male·Age: 18+
Code: NCT05223803·Phase 2·Recruiting·Listed Feb 2022
SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas
for Non Hodgkin Lymphoma
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: 18+
Code: NCT07222631·Phase 1, Phase 2·Recruiting·Listed Oct 2025
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC
for Advanced Renal Cell Carcinoma
Sites in La Jolla +3 more locations
Sponsor: Karie Runcie
Sex: All·Age: 18+
Code: NCT06863311·Phase 2·Recruiting·Listed Mar 2025
CapTemY90 for Grade 2/3 NET Liver Metastases
for Neuroendocrine Tumor Grade 2
Sites in La Jolla +3 more locations
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All·Age: 18+
Code: NCT04339036·Phase 2·Recruiting·Listed Apr 2020
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
for Anal Carcinoma
Sites in La Jolla, San Francisco +6 more locations
Sponsor: AIDS Malignancy Consortium
Sex: All·Age: 18+
Code: NCT05663502·Recruiting·Listed Dec 2022
Study of Personalized Cancer Therapy to Determine Response and Toxicity
for Cancer
Sites in La Jolla, San Diego & Rancho Mirage
Sponsor: Shu Mei Kato
Sex: All·Age: 7+
Code: NCT02478931·Recruiting·Listed Jun 2015
Retifanlimab and Ruxolitinib In Solid Malignancies
for Non Small Cell Lung Carcinoma
Drug: Retifanlimab
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: All ages
Code: NCT07219576·Phase 1, Phase 2·Recruiting·Listed Oct 2025
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
for Breast Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: 18+
Code: NCT07087691·Recruiting·Listed Jul 2025
Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
for Prostate Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Male·Age: 18+
Code: NCT06990542·Phase 2·Recruiting·Listed May 2025
Elranatamab in Relapsed/Refractory Multiple Myeloma
for Multiple Myeloma
Drug: Elranatamab
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: All·Age: 18+
Code: NCT06711705·Phase 2·Recruiting·Listed Dec 2024
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
for HIV
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Female·Age: 25 - 64
Code: NCT06128304·Recruiting·Listed Nov 2023
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
for Cancer
Sites in La Jolla, San Diego & Duarte
Sponsor: University of California, San Diego
Sex: All·Age: 0 - 50
Code: NCT05443737·Phase 3·Recruiting·Listed Jul 2022
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
for Cervical Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Female·Age: 18+
Code: NCT07121543·Recruiting·Listed Aug 2025
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)
for Prostate Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Male·Age: All ages
Code: NCT05882253·Recruiting·Listed May 2023
Focal Therapy for Localized Prostate Cancer
for Prostate Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Male·Age: 18+·Accepts healthy volunteers
Code: NCT06270043·Recruiting·Listed Feb 2024
Prostate Assessment with Restriction Spectrum Imaging (RSI) MRI
for Prostate Cancer
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Male·Age: 18+
Code: NCT04992728·Recruiting·Listed Aug 2021
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
for Gastric Cancer
Drug: Sonesitatug vedotin
Sites in La Jolla, Orange +70 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026
Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
for Prostate Adenocarcinoma
1 location in La Jolla
Sponsor: University of California, San Diego
Sex: Male·Age: 18+
Code: NCT07364071·Phase 2·Recruiting·Listed Jan 2026
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for Non-small Cell Lung Cancer (NSCLC)
Sites in La Jolla, San Diego +46 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07291037·Phase 3·Recruiting·Listed Dec 2025
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for Prostate Cancer
Drug: Saruparib
Sites in La Jolla, San Diego +35 more locations
Sponsor: AstraZeneca
Sex: Male·Age: 18+
Code: NCT06952803·Phase 3·Recruiting·Listed May 2025
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for Endometrial Cancer
Drug: Rilvegostomig
Sites in La Jolla, Irvine +46 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT06989112·Phase 3·Recruiting·Listed May 2025
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
for Endometrial Cancer
Sites in La Jolla, Orange +65 more locations
Sponsor: AstraZeneca
Sex: Female·Age: 18+
Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
for Biliary Tract Cancer
Drug: Rilvegostomig
Sites in La Jolla, Fullerton +29 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 99
Code: NCT06467357·Phase 3·Recruiting·Listed Jun 2024
Conditions in Oncology (La Jolla, CA)
Solid tumor· 29Non-small cell lung cancer (NSCLC)· 26Breast cancer· 18Prostate cancer· 14Colorectal cancer· 13Ovarian cancer· 12Pancreatic cancer· 11Head and neck cancer· 9Cancer (any)· 9Kidney cancer· 8Metastatic breast cancer· 6Endometrial cancer· 6Non-Hodgkin lymphoma· 6Hematologic malignancy· 6Triple-negative breast cancer· 5Gastric cancer· 4Cervical cancer· 4Melanoma· 4HER2-positive breast cancer· 3Lung cancer· 3Esophageal cancer· 3Liver cancer· 3Biliary tract cancer· 3Bladder cancer· 3Multiple myeloma· 3Chronic lymphocytic leukemia (CLL)· 3Small lymphocytic lymphoma· 3Mesothelioma· 3HER2-negative breast cancer· 2Colon cancer· 2Rectal cancer· 2Gastroesophageal junction cancer· 2Metastatic prostate cancer· 2Fallopian tube cancer· 2Glioblastoma· 2Myelodysplastic syndromes (MDS)· 2Myelofibrosis· 2Follicular lymphoma· 2Mantle cell lymphoma· 2Marginal zone lymphoma· 2Neuroendocrine tumors· 2Small cell lung cancer· 1Gastrointestinal cancer· 1Glioma· 1Brain cancer· 1Acute myeloid leukemia (AML)· 1Leukemia (other)· 1Myeloproliferative neoplasm· 1Hodgkin lymphoma· 1Diffuse large B-cell lymphoma (DLBCL)· 1Osteosarcoma· 1